Loading…
SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers, as well as offers boosters. The company was formerly known as The Beauty Health Company and changed its name to SkinHealth Systems Inc. in April 2026. The company was founded in 1997 and is headquartered in Long Beach, California.
5-year financial trends. Figures in USD millions.
Latest fiscal year: 2025
Year-by-year revenue, profitability, and cash flow (USD millions, last 10 years)
| Year | Revenue | EBITDA | Net Profit | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|
| 2025 | $301M | $39M | $-10M | $32M | -15.6% | -10.0% | -67.3% |
| 2024 | $334M | $15M | $-29M | $9M | -56.2% | -16.0% | -70.9% |
| 2023 | $398M | $-54M | $-100M | $9M | -168.6% | 8.8% | -326.4% |
| 2022 | $366M | $82M | $44M | $-124M | 26.5% | - | - |
| 2021 | - |
Income statement, balance sheet, and cash flow as reported
Consolidated Figures in USD Millions.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total Revenue | - | 365.88 | 397.99 | 334.29 | 300.79 |
| Operating Revenue | - | 365.88 | 397.99 | 334.29 | 300.79 |
| Cost Of Revenue | - | 117.10 | 242.88 | 152 | 104.43 |
| Gross Profit | - | 248.78 | 155.11 | 182.30 | 196.36 |
| Operating Expense | - | 274.62 | 286.03 | 250.07 | 217.17 |
| Research And Development | - | 8.44 | 10.10 | 6.30 | 5.63 |
| Selling General And Administration | - | 266.18 | 275.93 | 243.77 | 211.54 |
| Total Expenses | - | 391.72 | 528.91 | 402.07 | 321.59 |
| Operating Income | - | -25.84 | -130.92 | -67.77 | -20.80 |
| Total Operating Income As Reported | - | -25.84 | -130.92 | -67.77 | -20.80 |
| EBITDA | - | 81.60 | -53.56 | 14.54 | 38.74 |
| Normalized EBITDA | - | 4.56 | -67.87 | 16.11 | 32.43 |
| EBIT | - | 58.73 | -88.24 | -19.14 | 13.39 |
| Interest Income | - | 9.18 | 23.17 | 16.64 | 8.95 |
| Interest Expense | - | 13.39 | 13.65 | 10.41 | 19.33 |
| Net Interest Income | - | -4.22 | 9.52 | 6.23 | -10.37 |
| Other Non Operating Income Expenses | - | -1.65 | 5.20 | 33.56 | 18.93 |
| Other Income Expense | - | 75.40 | 19.50 | 31.99 | 25.24 |
| Interest Income Non Operating | - | 9.18 | 23.17 | 16.64 | 8.95 |
| Interest Expense Non Operating | - | 13.39 | 13.65 | 10.41 | 19.33 |
| Net Non Operating Interest Income Expense | - | -4.22 | 9.52 | 6.23 | -10.37 |
| Pretax Income | - | 45.34 | -101.89 | -29.55 | -5.94 |
| Tax Provision | - | 1.12 | -1.77 | -0.45 | 3.58 |
| Tax Rate For Calcs | - | 0 | 0 | 0 | 0 |
| Tax Effect Of Unusual Items | - | 1.85 | 0.25 | -0.02 | 1.32 |
| Net Income Continuous Operations | - | 44.22 | -100.12 | -29.10 | -9.52 |
| Net Income From Continuing And Discontinued Operation | - | 44.22 | -100.12 | -29.10 | -9.52 |
| Net Income From Continuing Operation Net Minority Interest | - | 44.22 | -100.12 | -29.10 | -9.52 |
| Net Income | - | 44.22 | -100.12 | -29.10 | -9.52 |
| Net Income Common Stockholders | - | 44.22 | -100.12 | -29.10 | -9.52 |
| Net Income Including Noncontrolling Interests | - | 44.22 | -100.12 | -29.10 | -9.52 |
| Normalized Income | - | -30.97 | -114.17 | -27.55 | -14.50 |
| Diluted NI Availto Com Stockholders | - | -34.12 | -100.12 | -51.77 | -22.11 |
| Basic Average Shares | - | 147.55 | 131.68 | 123.83 | 126.38 |
| Diluted Average Shares | - | 148.51 | 131.68 | 123.83 | 135.80 |
| Reconciled Depreciation | - | 22.87 | 34.67 | 33.68 | 25.35 |
| Reconciled Cost Of Revenue | - | 117.10 | 242.88 | 152 | 104.43 |
| Total Unusual Items | - | 77.05 | 14.30 | -1.57 | 6.31 |
| Total Unusual Items Excluding Goodwill | - | 77.05 | 14.30 | -1.57 | 6.31 |
| Gain On Sale Of Security | - | 77.05 | 14.30 | -1.57 | 6.31 |
| General And Administrative Expense | - | 106.10 | 131.43 | 125.46 | 117.95 |
| Other Gand A | - | 106.10 | 131.43 | 125.46 | 117.95 |
| Selling And Marketing Expense | - | 160.08 | 144.50 | 118.31 | 93.59 |
| Average Dilution Earnings | - | -78.34 | 0 | -22.67 | -12.59 |
Consumer Defensive sector peers, ranked by market cap
| Company | Ticker | Market Cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|---|
| SkinHealth Systems Inc.this co. | SKIN | $79M | - | 1.30 | -15.6% | 5.81 |
| LifeVantage Corporation | LFVN | $117M | 11.98 | 3.39 | 28.3% | 7.09 |
| Zevia PBC | ZVIA | $100M | -10.13 | 1.97 | -19.4% | -8.66 |
| HF Foods Group Inc. | HFFG | $98M | -2.53 | 0.49 | -19.2% | -57.51 |
| Ispire Technology Inc. | ISPR | $95M | - |
| - |
| - |
| - |
| - |
| - |
| - |
| 158.80 |
| -6540.0% |
| - |
| Solesence, Inc. | SLSN | $95M | 53.07 | 5.39 | 10.2% | 31.98 |
| FitLife Brands, Inc. | FTLF | $93M | 14.76 | 2.14 | 14.5% | 13.03 |
| The Hain Celestial Group, Inc. | HAIN | $69M | -0.13 | 0.15 | -111.8% | -1.90 |
| Skillsoft Corp. | SKIL | $64M | -0.46 | -2.12 | 462.6% | 16.11 |
| Peer Median | - | -0.13 | 2.05 | -4.5% | 7.09 | |